We recently published a list of 10 Unexpected Market Movers—What Propelled Double-Digit Gains? In this article, we are going to take a look at where Dentsply Sirona Inc. (NASDAQ:XRAY) stands against other Thursday’s top-performing stocks. The stock market extended its winning streak on Thursday as investors cheered President Donald Trump’s trade deal framework between the United States and the United Kingdom. Among Wall Street’s major indices, the tech-heavy Nasdaq rallied the most, up 1.07 percent, followed by the Dow Jones, up 0.62 percent, and the S&P 500, gaining 0.58 percent. According to Trump, the Oval Office outlined a trade deal framework. While a 10-percent baseline tariff will remain for imported goods from the UK, it could be the low end of deals with future countries. “The final details are being written up,” Trump said. “In the coming weeks, we’ll have it all very conclusive.” Beyond the major indices, 10 firms stood out, booking double-digit gains amid a flurry of fresh developments such as optimistic revenue guidance and impressive earnings performance, among others. In this article, let us explore Thursday’s 10 top-performing stocks and detail the reasons behind their gains. To come up with the list, we considered only the stocks with a $2-billion market capitalization and $5-million trading volume.Why Dentsply Sirona Inc. (XRAY) Went Up On Thursday A doctor adjusting dental equipment in a modern dental clinic. Dentsply Sirona Inc. (NASDAQ:XRAY) Dentsply Sirona, one of the leading dental equipment manufacturers globally, saw its share prices jump by 16.30 percent on Thursday to close at $15.91 apiece as investors cheered its improved earnings performance and beat of analysts’ estimates. In its latest earnings release, Dentsply Sirona Inc. (NASDAQ:XRAY) said that attributable net income increased by 11 percent to $20 million from the $18 million reported in the same period last year. Net sales, on the other hand, dropped by 7.8 percent to $879 million from $953 million year-on-year, weighed down by foreign currency changes, which dented its net sales by approximately $30 million. For the rest of the year, Dentsply Sirona Inc. (NASDAQ:XRAY) maintained its previous growth outlook, with revenues targeted to settle at $3.6 billion to $3.7 billion, and organic sales to drop by 2 to 4 percent. Overall, XRAY ranks 8th on our list of Thursday’s top-performing stocks. While we acknowledge the potential of XRAY as an investment, our conviction lies in the belief that AI stocks hold greater promise for delivering higher returns and doing so within a shorter time frame. There is an AI stock that went up since the beginning of 2025, while popular AI stocks lost around 25%. If you are looking for an AI stock that is more promising than XRAY but that trades at less than 5 times its earnings, check out our report about this cheapest AI stock. Story Continues READ NEXT: 20 Best AI Stocks To Buy Now and 30 Best Stocks to Buy Now According to Billionaires. Disclosure: None. This article is originally published at Insider Monkey. View Comments
Why Dentsply Sirona Inc. (XRAY) Went Up On Thursday
You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research. Learn more
Start Your Free Trial Now!Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research ReportsThis information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.
Please wait processing your request...